click below
click below
Normal Size Small Size show me how
WEEK 3:
Liver failure:
| Question | Answer |
|---|---|
| hepatotoxicity | liver damage caused by chemical or substance (eg paracetamol overdose, certain antibiotics, alcohol and other medications and toxic substances) |
| where is the liver located mainly | right upper quadrant of the abdomen (beneath diaphragm and above stomach, right kidney and intestines) |
| portal vein | delivers nutrient rich blood from gastrointestinal tract |
| hepatic artery | delivers oxygen rich blood |
| bile duct | carries bile away from liver |
| movement of blood out liver | blood leaves liver through hepatic veins which drain into inferior vena cava |
| movement of blood into the liver | via portal vein and hepatic artery |
| DILLI can be caused by | overdose or even can occur when a medication is taken at an appropriate dose |
| things than can lead to liver tissue damage | reduced oxygen (hepatocyte injury and necrosis), drugs causing hepatocellular injury or cholestasis, inflammation causing cell damage of scarring, and repeated injury can cause fibrosis |
| liver injury leads to | cell damage and inflammation (Cell death, oxidative injury and immune responses) leading to either recovery or chronic damage |
| Hepatocyte necrosis | Death of liver cells due to severe injury, often associated with inflammation. |
| Cholestasis | Reduced formation or flow of bile |
| Reperfusion/oxidation injury | Tissue damage associated with the return of blood supply and oxidative stress. |
| Dysplasia | Abnormal cellular growth and organisation. |
| Neoplasia | New, uncontrolled cell growth that may be benign or malignant. |
| how does fibrosis develop | repeated or persistent injury activates hepatic stellate cells which produce collagen and other ECM components so as scar tissue accumulates, normal architecture of liver becomes distorted |
| cirrhosis | advanced widespread fibrosis with regenerative nodule formation |
| jaundice | yellow discolouration of skin, sclera and mucous membranes caused by increased bilirubin in blood |
| bilirubin | yellow pigment produced mainly when old RBC broken down |
| explain the progression into developing jaundice | old RBC break down so haem converted into bilirubin which is not water soluble so travels bound to albumin in blood + liver converts it into water soluble form (conjugated) and bile carries it to intestine where most pigment is eliminated in faeces/urine |
| normal bilirubin | below 17 µmol/L. |
| jaundice level of bilirubin | above approximately 60 µmol/L |
| Unconjugated hyperbilirubinaemia | unconjugated bilirubin is raised. |
| Conjugated hyperbilirubinaemia | conjugated bilirubin is raised |
| enterohepatic circulation | circulation of substances from liver into bile and intestine followed by reabsorption from intestine and return to liver via portal circulation (needed for bile acid recycling) |
| Pre-hepatic jaundice | too much bilirubin produced eg haemolysis, thalassaemia and other haemoglobin disorders |
| hepatic (hepatocellular) jaundice | liver cannot process or excrete bilirubin normally eg viral hepatitis, toxic hepatitis and intrahepatic cholestasis |
| post hepatic (obstructive) jaundice | conjugated bilirubin cannot flow normally into the intestine eg gallstones, bile duct tumours and pancreatic cancer |
| liver enzymes for liver function test includes (4) | ALT/ AST/ ALP/ GGT |
| ALT and AST indicates | liver cell injury |
| ALP and GGT indicates | help identify a cholestatic pattern |
| bilirubin test indicates | bilirubin processing and excretion |
| prothrombin time/ INR indicates | liver synthetic function although other factors affect it |
| albumin indicates | protein synthesis although other conditions affect its level |
| platelets indicate | a low count can be a clue to liver fibrosis and portal hypertension |
| acute hepatic failure | severe rapidly developing liver dysfunction typically with coagulopathy and hepatic encephalopathy in someone without preexisting cirrhosis (can occur in previously healthy liver) |
| jaundice | bilirubin accumulates |
| Hepatic encephalopathy: | brain dysfunction, ranging from confusion to coma. |
| Coagulopathy: | reduced production of clotting factors, causing a prolonged INR. |
| Causes of acute hepatic failure | Paracetamol overdose. Drug-induced liver injury (DILI). Acute viral hepatitis. Ischaemic liver injury. |
| specific antidote for paracetamol | N-acetylcysteine (NAC) (given in 4 first hours) |
| acute liver failure can cause | multi organ failure |
| what might be needed for acute liver failure | liver transplantation but if patient recovers the liver may regenerate without significant fibrosis |
| uses of Bilirubin, prothrombin time/INR and albumin | Bilirubin, prothrombin time/INR and albumin |
| Causes of chronic liver disease | Alcohol-related liver disease (ARLD). Hepatitis B and C. Fatty liver disease (called NAFLD in your slides). Autoimmune liver disease. Metabolic or congenital disease. Drug-induced or toxic liver injury. |
| Cirrhosis | a histological condition characterised by diffuse hepatic fibrosis and regenerative nodule formation. |
| Persistent liver injury can cause | fibrosis and eventually cirrhosis. |
| Cirrhosis distorts | normal liver architecture |
| LFTs can be normal even when | cirrhosis is present |
| FibroScan measures | liver stiffness to help assess fibrosis. |
| Cirrhosis increases the risk of | hepatocellular carcinoma (HCC) and portal hypertension |
| symptoms | Fatigue. Loss of appetite and weight. Dull right upper-quadrant pain. Pruritus. Mild jaundice. Arthralgia. |
| bilirubin is uncojugated when | before liver processes it |
| ALP and GGT are associated with | cholestatic pattern |
| INR helps assess | impaired clotting factor synthesis |
| NAPQI is | toxic metabolite in paracetamol related liver injury when detoxification capacity is overwhelmed |
| portal hypertension can cause | oesophageal varices which can bleed |